Journal
SAUDI JOURNAL OF BIOLOGICAL SCIENCES
Volume 29, Issue 11, Pages -Publisher
ELSEVIER
DOI: 10.1016/j.sjbs.2022.103465
Keywords
SARS-CoV-2; COVID-19; Detection methods; RT-qPCR; Specimens; Serology; Variants
Categories
Funding
- Institute for Research and Medical Consultations (IRMC) [COVID19- 2020-026-IRMC]
- Deanship of Scientific Research (DSR) of Imam Abdulrahman Bin Faisal University (IAU)
- [2020-IRMC-S-3]
Ask authors/readers for more resources
Since its declaration as a pandemic in March 2020, COVID-19 has been the center of attention due to its rapid and uncontrollable spread. Diagnostic tests, such as RT-qPCR, are widely used for detecting SARS-CoV-2, but alternative tests are being explored to meet the global demand. This review summarizes the recent updates on SARS-CoV-2 detection methods and their limitations, aiming to guide researchers and clinicians in identifying more rapid, reliable, and sensitive diagnostic methods.
The ongoing novel COVID-19 has remained the center of attention, since its declaration as a pandemic in March 2020, due to its rapid and uncontrollable worldwide spread. Diagnostic tests are the first line of defense against the transmission of this infectious disease among individuals, with reversetranscription quantitative polymerase chain reaction (RT-qPCR) being the approved gold standard for showing high sensitivity and specificity in detecting SARS-CoV-2. However, alternative tests are being invested due to the global demand for facilities, reagents, and healthcare workers needed for rapid population-based testing. Also, the rapid evolution of the viral genome and the emergence of new variants necessitates updating the existing methods. Scientists are aiming to improve tests to be affordable, simple, fast, and at the same time accurate, and efficient, as well as friendly user testing. The current diagnostic methods are either molecular-based that detect nucleic acids abundance, like RT-qPCR and reverse-transcription loop-mediated isothermal amplification (RT-LAMP); or immunologically based that detect the presence of antigens or antibodies in patients' specimens, like enzyme-linked immunosorbent assay (ELISA), lateral flow assay (LFA), chemiluminescent immunoassay (CLIA), and neutralization assay. In addition to these strategies, sensor-based or CRISPR applications are promising tools for the rapid detection of SARS-CoV-2. This review summarizes the most recent updates on the SARS-CoV-2 detection methods with their limitations. It will guide researchers, epidemiologists, and clinicians in identifying a more rapid, reliable, and sensitive method of diagnosing SARS-CoV-2 including the most recent variant of concern Omicron. (c) 2022 The Author(s). Published by Elsevier B.V. on behalf of King Saud University. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available